Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adolesco is a Swedish medical device company focused on nuclear cardiology imaging. The company is known for Cardiotom, a mobile 3D gamma camera designed for bedside cardiac perfusion imaging in settings such as intensive care units, emergency rooms, and physician offices. Cardiotom was developed in collaboration with researchers from Karolinska Hospital, Karolinska Institutet, Novum Research Park, and KTH in Stockholm, and Adolesco has been responsible for its development, production, commercialization, and marketing. The system is positioned as a self-contained, fast-imaging device intended to improve access to cardiac diagnostic imaging without moving critically ill patients. Based on the available evidence, Adolesco appears to be a small, private, active medtech company rather than a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adolesco.